Get the Stockscreener App
2.32
0.87%
0.02
After Hours:
2.39
0.07
+3.02%
Vicarious Surgical Inc stock is traded at $2.32, with a volume of 87,306.
It is up +0.87% in the last 24 hours and up +18.97% over the past month.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.
See More
Previous Close:
$2.30
Open:
$2.36
24h Volume:
87,306
Relative Volume:
0.63
Market Cap:
$16.51M
Revenue:
-
Net Income/Loss:
$-59.63M
P/E Ratio:
-0.2302
EPS:
-10.0762
Net Cash Flow:
$-49.92M
1W Performance:
-9.73%
1M Performance:
+18.97%
6M Performance:
-79.32%
1Y Performance:
-81.88%
1-Day Range:
$2.25
$2.42
1-Week Range:
$2.23
$2.75
52-Week Range:
$1.805
$16.35
Vicarious Surgical Inc Stock (RBOT) Company Profile
Name
Vicarious Surgical Inc
Sector
Industry
Phone
(617) 868-1700
Address
78 FOURTH AVENUE, WALTHAM
Compare RBOT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
2.32 | 16.37M | 0 | -59.63M | -49.92M | -10.08 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Vicarious Surgical Inc Stock (RBOT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-07-22 | Initiated | Credit Suisse | Outperform |
| Dec-07-21 | Initiated | Cowen | Outperform |
| Nov-05-21 | Initiated | Canaccord Genuity | Buy |
| Oct-18-21 | Initiated | BTIG Research | Buy |
| Oct-07-21 | Initiated | Piper Sandler | Overweight |
View All
Vicarious Surgical Inc Stock (RBOT) Latest News
Take Profit: Does Vicarious Surgical Inc Equity Warrant stock benefit from AI growth2025 Trading Recap & Real-Time Price Movement Reports - baoquankhu1.vn
Tactile Systems Technology (NASDAQ:TCMD) & Vicarious Surgical (NYSE:RBOT) Critical Survey - Defense World
Layoff Watch: Is Vicarious Surgical Inc forming a bullish divergenceMarket Performance Report & Momentum Based Trading Signals - baoquankhu1.vn
Momentum Shift: Can Vicarious Surgical Inc outperform under higher oil prices2025 Market Trends & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Price-Driven Insight from (RBOT) for Rule-Based Strategy - Stock Traders Daily
RSI Check: Is Vicarious Surgical Inc Equity Warrant stock resilient to inflationQuarterly Portfolio Summary & Real-Time Chart Breakout Alerts - Bộ Nội Vụ
Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab - marketscreener.com
Inside the animal lab shaping tomorrow's robotic hernia surgery - Stock Titan
Wall Street Zen Upgrades Vicarious Surgical (NYSE:RBOT) to “Hold” - Defense World
Vicarious Surgical Stockholders Approve Warrant Exercise Proposal - TipRanks
Vicarious Surgical Forges Strategic Software Execution Partnership - Medical Product Outsourcing
Financial Review: Vicarious Surgical (NYSE:RBOT) vs. NeuroPace (NASDAQ:NPCE) - Defense World
Stop Loss: What margin trends mean for Vicarious Surgical Inc. Equity Warrant stockJuly 2025 Drop Watch & Technical Entry and Exit Alerts - Улправда
Is Vicarious Surgical Inc. Equity Warrant stock cheap compared to fundamentalsJuly 2025 Rallies & Capital Protection Trading Alerts - Улправда
Can Vicarious Surgical Inc. stock rebound after recent weaknessWall Street Watch & Low Risk Entry Point Tips - Улправда
Can Vicarious Surgical Inc. Equity Warrant stock sustain revenue growthEarnings Overview Summary & Free Safe Capital Growth Stock Tips - Улправда
Why Vicarious Surgical Inc. Equity Warrant stock could be next big winner2025 Momentum Check & Weekly High Return Opportunities - Улправда
Is Vicarious Surgical Inc. stock a contrarian buyEarnings Growth Summary & Verified Momentum Stock Ideas - ulpravda.ru
Update Recap: Is Vicarious Surgical Inc. stock a defensive play in 2025July 2025 Summary & Consistent Return Investment Signals - Улправда
Why analysts upgrade Vicarious Surgical Inc. stock2025 Valuation Update & Weekly High Conviction Ideas - Улправда
Is Vicarious Surgical Inc. stock trading near support levelsJuly 2025 Update & Free Safe Entry Trade Signal Reports - Улправда
Is Vicarious Surgical Inc. Equity Warrant stock gaining market share2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - Улправда
Is Vicarious Surgical Inc. stock a defensive play in 2025Market Sentiment Summary & Daily Risk Controlled Trade Plans - Улправда
What margin trends mean for Vicarious Surgical Inc. Equity Warrant stockJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - Улправда
What catalysts could drive Vicarious Surgical Inc. stock higherTake Profit Strategies & Superior Wealth Strategies - Улправда
Vicarious inks software partnership as it streamlines operations - MedTech Dive
How Vicarious Surgical Inc stock performs in interest rate cycles2025 Volatility Report & Safe Capital Allocation Plans - Bộ Nội Vụ
(RBOT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Published on: 2026-01-02 13:06:23 - moha.gov.vn
Vicarious Surgical announces 2026 cash burn guidance - MSN
RBOT enters strategic software partnership to streamline development - MSN
RBOT Enters Strategic Software Partnership to Streamline Development - The Globe and Mail
D8 (RBOT) - Zacks Investment Research
Vicarious Surgical announces strategic software execution partnership - Medical Buyer
Vicarious Surgical partners with global engineering firm to cut costs By Investing.com - Investing.com Nigeria
Vicarious Surgical announces strategic software execution partnership to streamline operations - MarketScreener
Vicarious Surgical Announces Strategic Software Execution Partnership To Streamline Operations - TradingView — Track All Markets
Vicarious Surgical Announces Strategic Software Execution Partnership to Streamline Operations - Ortho Spine News
Vicarious Surgical partners with global engineering firm to cut costs - Investing.com
Inside the software shakeup powering Vicarious Surgical’s robot push - Stock Titan
Precision Trading with Vicarious Surgical Inc. Class A (RBOT) Risk Zones - Stock Traders Daily
Dilution adjustment of Vicarious Surgical Inc. – OTC:RBOTW - TradingView — Track All Markets
Vicarious Surgical (RBOT) Price Target Decreased by 44.44% to 5.10 - Nasdaq
Aug Reactions: Is Vicarious Surgical Inc. stock in correction or buying zoneJuly 2025 Macro Moves & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
Sentiment Review: Will Vicarious Surgical Inc. Equity Warrant stock benefit from infrastructure spendingEntry Point & AI Based Buy and Sell Signals - Улправда
How Vicarious Surgical Inc. Equity Warrant stock benefits from strong dollarJuly 2025 Reactions & Weekly Watchlist for Hot Stocks - Улправда
Is Vicarious Surgical Inc. Class stock a buy before earnings resultsJuly 2025 Action & Long Hold Capital Preservation Tips - Улправда
Can Vicarious Surgical Inc. Equity Warrant stock hit analyst price targetsJuly 2025 Reactions & Free Risk Controlled Daily Trade Plans - Улправда
Check out Vicarious Surgical Equity Warrants Exp 17 Sept 2026's stock price (RBOTW) in real time - CNBC
Is Vicarious Surgical Inc. stock affected by interest rate hikesWeekly Market Outlook & High Win Rate Trade Alerts - DonanımHaber
Is Vicarious Surgical Inc. Warrants each stock positioned for digital growth era2025 Market Outlook & Free AI Powered Buy and Sell Recommendations - DonanımHaber
Vicarious Surgical Inc Stock (RBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):